| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc. | CHIEF TECHNOLOGY OFFICER | Ordinary Shares | 119K | $812K | $6.84 | Jul 1, 2025 | Direct |
| Structure Therapeutics Inc. | CHIEF TECHNOLOGY OFFICER | Employee Stock Option (right to buy) | 155K | Mar 15, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GPCR | Structure Therapeutics Inc. | Jul 1, 2025 | 1 | -$30.6K | 4 | Aug 20, 2025 | CHIEF TECHNOLOGY OFFICER |
| GPCR | Structure Therapeutics Inc. | Mar 15, 2025 | 2 | $0 | 4 | Mar 18, 2025 | CHIEF TECHNOLOGY OFFICER |
| GPCR | Structure Therapeutics Inc. | Mar 1, 2025 | 2 | -$14.4K | 4 | Jul 3, 2025 | CHIEF TECHNOLOGY OFFICER |
| GPCR | Structure Therapeutics Inc. | Mar 15, 2024 | 1 | $0 | 4/A | Mar 20, 2024 | CHIEF TECHNOLOGY OFFICER |
| GPCR | Structure Therapeutics Inc. | Mar 15, 2024 | 2 | $0 | 4 | Mar 19, 2024 | CHIEF TECHNOLOGY OFFICER |
| GPCR | Structure Therapeutics Inc. | Feb 2, 2023 | 0 | $0 | 3 | Feb 2, 2023 | Chief Technology Officer |